FARMACEUTISKE SAMMENSÆTNINGER AF 3-(6-(1-(2,2-DIFLUORBENZO[D][1,3]DIOXOL-5-YL)-CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOESYRE OG INDGIVELSE DERAF

A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the compo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VERWIJS, Marinus, Jacobus, KADIYALA, Irina, Nikolaevna, KAUSHIK, Ritu, Rohit, ALARGOVA, Rossitza, Gueorguieva, YOUNG, Christopher, Ryan
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.